The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Botanical and Plant Derived Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.
The global Botanical and Plant Derived Drugs market size is expected to reach US$ 37100 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Botanical and Plant Derived Drugs in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Drug Stores, are propelling Botanical and Plant Derived Drugs market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Botanical and Plant Derived Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Botanical and Plant Derived Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Botanical and Plant Derived Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Botanical and Plant Derived Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Botanical and Plant Derived Drugs covered in this report include Abott Laboratories, Bayer Healthcare, Bionova, Bristol Myers and Curapharm, etc.
The global Botanical and Plant Derived Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abott Laboratories
Bayer Healthcare
Bionova
Bristol Myers
Curapharm
Global Botanical and Plant Derived Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Botanical and Plant Derived Drugs market, Segment by Type:
Tablets
Capsules
Pills
Injections
Global Botanical and Plant Derived Drugs market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Botanical and Plant Derived Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.
The global Botanical and Plant Derived Drugs market size is expected to reach US$ 37100 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Botanical and Plant Derived Drugs in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Drug Stores, are propelling Botanical and Plant Derived Drugs market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Botanical and Plant Derived Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Botanical and Plant Derived Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Botanical and Plant Derived Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Botanical and Plant Derived Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Botanical and Plant Derived Drugs covered in this report include Abott Laboratories, Bayer Healthcare, Bionova, Bristol Myers and Curapharm, etc.
The global Botanical and Plant Derived Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abott Laboratories
Bayer Healthcare
Bionova
Bristol Myers
Curapharm
Global Botanical and Plant Derived Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Botanical and Plant Derived Drugs market, Segment by Type:
Tablets
Capsules
Pills
Injections
Global Botanical and Plant Derived Drugs market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Botanical and Plant Derived Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Botanical and Plant Derived Drugs
1.1 Botanical and Plant Derived Drugs Market Overview
1.1.1 Botanical and Plant Derived Drugs Product Scope
1.1.2 Botanical and Plant Derived Drugs Market Status and Outlook
1.2 Global Botanical and Plant Derived Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Botanical and Plant Derived Drugs Market Size by Region (2018-2029)
1.4 Global Botanical and Plant Derived Drugs Historic Market Size by Region (2018-2023)
1.5 Global Botanical and Plant Derived Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Botanical and Plant Derived Drugs Market Size (2018-2029)
1.6.1 North America Botanical and Plant Derived Drugs Market Size (2018-2029)
1.6.2 Europe Botanical and Plant Derived Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Botanical and Plant Derived Drugs Market Size (2018-2029)
1.6.4 Latin America Botanical and Plant Derived Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Botanical and Plant Derived Drugs Market Size (2018-2029)
2 Botanical and Plant Derived Drugs Market by Type
2.1 Introduction
2.1.1 Tablets
2.1.2 Capsules
2.1.3 Pills
2.1.4 Injections
2.2 Global Botanical and Plant Derived Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Botanical and Plant Derived Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Botanical and Plant Derived Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Botanical and Plant Derived Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Botanical and Plant Derived Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Botanical and Plant Derived Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Botanical and Plant Derived Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Botanical and Plant Derived Drugs Revenue Breakdown by Type (2018-2029)
3 Botanical and Plant Derived Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.1.4 Drug Stores
3.2 Global Botanical and Plant Derived Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Botanical and Plant Derived Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Botanical and Plant Derived Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Botanical and Plant Derived Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Botanical and Plant Derived Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Botanical and Plant Derived Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Botanical and Plant Derived Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Botanical and Plant Derived Drugs Revenue Breakdown by Application (2018-2029)
4 Botanical and Plant Derived Drugs Competition Analysis by Players
4.1 Global Botanical and Plant Derived Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Botanical and Plant Derived Drugs as of 2022)
4.3 Date of Key Players Enter into Botanical and Plant Derived Drugs Market
4.4 Global Top Players Botanical and Plant Derived Drugs Headquarters and Area Served
4.5 Key Players Botanical and Plant Derived Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Botanical and Plant Derived Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abott Laboratories
5.1.1 Abott Laboratories Profile
5.1.2 Abott Laboratories Main Business
5.1.3 Abott Laboratories Botanical and Plant Derived Drugs Products, Services and Solutions
5.1.4 Abott Laboratories Botanical and Plant Derived Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Abott Laboratories Recent Developments
5.2 Bayer Healthcare
5.2.1 Bayer Healthcare Profile
5.2.2 Bayer Healthcare Main Business
5.2.3 Bayer Healthcare Botanical and Plant Derived Drugs Products, Services and Solutions
5.2.4 Bayer Healthcare Botanical and Plant Derived Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Healthcare Recent Developments
5.3 Bionova
5.3.1 Bionova Profile
5.3.2 Bionova Main Business
5.3.3 Bionova Botanical and Plant Derived Drugs Products, Services and Solutions
5.3.4 Bionova Botanical and Plant Derived Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Bristol Myers Recent Developments
5.4 Bristol Myers
5.4.1 Bristol Myers Profile
5.4.2 Bristol Myers Main Business
5.4.3 Bristol Myers Botanical and Plant Derived Drugs Products, Services and Solutions
5.4.4 Bristol Myers Botanical and Plant Derived Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Bristol Myers Recent Developments
5.5 Curapharm
5.5.1 Curapharm Profile
5.5.2 Curapharm Main Business
5.5.3 Curapharm Botanical and Plant Derived Drugs Products, Services and Solutions
5.5.4 Curapharm Botanical and Plant Derived Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Curapharm Recent Developments
6 North America
6.1 North America Botanical and Plant Derived Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Botanical and Plant Derived Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Botanical and Plant Derived Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Botanical and Plant Derived Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Botanical and Plant Derived Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Botanical and Plant Derived Drugs Market Dynamics
11.1 Botanical and Plant Derived Drugs Industry Trends
11.2 Botanical and Plant Derived Drugs Market Drivers
11.3 Botanical and Plant Derived Drugs Market Challenges
11.4 Botanical and Plant Derived Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
